Brain zap trial hopes to quiet OCD for good

NCT ID NCT05623306

Recruiting now Disease control Sponsor: Casey H. Halpern, M.D. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to treat severe obsessive-compulsive disorder (OCD) that hasn't improved with other treatments. Researchers will use brain mapping to guide the placement of four electrodes that deliver mild electrical pulses to specific brain areas. The goal is to see if this approach can safely reduce OCD symptoms. The trial involves 12 adults and includes a blinded phase where some participants receive active stimulation and others receive sham (inactive) stimulation to compare results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obsessive-compulsive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBSESSIVE-COMPULSIVE DISORDER

Contacts and locations

Locations

Stanford University
ACTIVE_NOT_RECRUITING

Stanford, California, 94304, United States
University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.